Review



values for levofloxacin  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    ATCC values for levofloxacin
    Values For Levofloxacin, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/values+for+levofloxacin/Streptococcus+pneumoniae/pm22210757-56-67-84
    Average 95 stars, based on 49 article reviews
    values for levofloxacin - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.
    Article Snippet: The lung colony counts with chinfloxacin treatments were generally not significantly different (P.0.05) from the corresponding values for moxifloxacin treatments (6.69– 4.33 log cfu/g for chinfloxacin versus 6.71–4.06 log cfu/g for moxifloxacin for S. pneumoniae ATCC 6301 at 12.5–100 mg/kg dose levels; 5.92–4.23 log cfu/g for chinfloxacin versus 5.91–4.08 log cfu/g for moxifloxacin for S. pneumoniae 0062 at 12.5–100 mg/kg), but much lower (P,0.01) than the corresponding values for levofloxacin (6.10–4.33 log cfu/g for chinfloxacin versus 7.11–5.64 log cfu/g for levofloxacin for S. pneumoniae ATCC 6301 at 25–100 mg/kg; 5.31–4.23 log cfu/g for chinfloxacin versus 6.06–5.13 log cfu/g for levofloxacin for S. pneumoniae 0062 at 25–100 mg/kg) and ciprofloxacin (5.26–4.33 log cfu/g for chinfloxacin versus 7.26–6.80 log cfu/g for ciprofloxacin for S. pneumoniae ATCC 6301 at 50–100 mg/kg; 4.91–4.23 log cfu/g for chinfloxacin versus 6.24–5.70 log cfu/g for ciprofloxacin for S. pneumoniae 0062 at 50–100 mg/kg).



    Similar Products

    values for levofloxacin  (ATCC)
    95
    ATCC values for levofloxacin
    Values For Levofloxacin, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/values+for+levofloxacin/Streptococcus+pneumoniae/pm22210757-56-67-84
    Average 95 stars, based on 1 article reviews
    values for levofloxacin - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    mic values against levofloxacin  (ATCC)
    99
    ATCC mic values against levofloxacin
    In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
    Mic Values Against Levofloxacin, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/values+for+levofloxacin/MIC/pmc08343939-139-22-55
    Average 99 stars, based on 1 article reviews
    mic values against levofloxacin - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    mouse systemic infection organism challenge dose cfu mouse nemonoxacin levofloxacin p value mic nemonoxacin levofloxacin p value mic mg l ed50  (ATCC)
    99
    ATCC mouse systemic infection organism challenge dose cfu mouse nemonoxacin levofloxacin p value mic nemonoxacin levofloxacin p value mic mg l ed50
    In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
    Mouse Systemic Infection Organism Challenge Dose Cfu Mouse Nemonoxacin Levofloxacin P Value Mic Nemonoxacin Levofloxacin P Value Mic Mg L Ed50, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/values+for+levofloxacin/MIC/10__2147_slash_dddt__s63581-55-96-120
    Average 99 stars, based on 1 article reviews
    mouse systemic infection organism challenge dose cfu mouse nemonoxacin levofloxacin p value mic nemonoxacin levofloxacin p value mic mg l ed50 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control

    Journal: Chinese Medicine

    Article Title: Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa

    doi: 10.1186/s13020-021-00481-8

    Figure Lengend Snippet: In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control

    Article Snippet: Fig. 1 In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC.

    Techniques: In Vitro, Control

    Active antibiofilm compounds from metabolites of CA in LJF. a Antibiofilm activity of LJF and CA. b Growth curves of bacterial growth at different sub-MICs of CA. c GC–MS analysis of CA at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of CA. d Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of CA. e Metabolic pathways of CA in intestine (left) and liver (right). f In vitro antibiofilm effects of CA and its intestinal metabolites. g In vitro antibiofilm effects of CA and its liver metabolites. h GC–MS analysis of quinic acid at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of quinic acid. i Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of quinic acid. j The antibacterial activity ratio of caffeic acid and quinic acid to CA. k The antibacterial activity ratio of caffeic acid and its main metabolites to CA. l , m The antibacterial activity ratio of quinic acid and its major metabolites to CA. n – o Effects of dihydrocaffeic acid and gallic acid on the integrity (n) and the permeability (o) of bacteria membrane against MRSA. p - q Effects of dihydrocaffeic acid on the integrity ( p ) and the permeability ( q ) of bacteria membrane against MSSA. r Effects of quinic acid on EPS secretion in biofilm formation (upper) and in mature biofilm (lower). s – u The synergistic antibiofilm effects of sub-MIC quinic acid with levofloxacin ( s ), clarithromycin ( t ) and azithromycin ( v ). QA: quinic acid. *P < 0.05, **P < 0.01, compared with corresponding control

    Journal: Chinese Medicine

    Article Title: Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa

    doi: 10.1186/s13020-021-00481-8

    Figure Lengend Snippet: Active antibiofilm compounds from metabolites of CA in LJF. a Antibiofilm activity of LJF and CA. b Growth curves of bacterial growth at different sub-MICs of CA. c GC–MS analysis of CA at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of CA. d Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of CA. e Metabolic pathways of CA in intestine (left) and liver (right). f In vitro antibiofilm effects of CA and its intestinal metabolites. g In vitro antibiofilm effects of CA and its liver metabolites. h GC–MS analysis of quinic acid at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of quinic acid. i Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of quinic acid. j The antibacterial activity ratio of caffeic acid and quinic acid to CA. k The antibacterial activity ratio of caffeic acid and its main metabolites to CA. l , m The antibacterial activity ratio of quinic acid and its major metabolites to CA. n – o Effects of dihydrocaffeic acid and gallic acid on the integrity (n) and the permeability (o) of bacteria membrane against MRSA. p - q Effects of dihydrocaffeic acid on the integrity ( p ) and the permeability ( q ) of bacteria membrane against MSSA. r Effects of quinic acid on EPS secretion in biofilm formation (upper) and in mature biofilm (lower). s – u The synergistic antibiofilm effects of sub-MIC quinic acid with levofloxacin ( s ), clarithromycin ( t ) and azithromycin ( v ). QA: quinic acid. *P < 0.05, **P < 0.01, compared with corresponding control

    Article Snippet: Fig. 1 In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC.

    Techniques: Activity Assay, Gas Chromatography-Mass Spectrometry, In Vitro, Permeability, Bacteria, Membrane, Control